Lung cancer is the leading cause of cancer deaths all across the world. It accounts for about 1.8m deaths every year. Doctors have begun trailing the world’s first lung cancer vaccine mRNA…
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
Osimertinib Plus Chemo Approved as Ist-Line Treatment for Patients with Lung Cancer
Lung cancer is the leading cause of cancer deaths among both men and women. It broadly splits into NSCLC and small cell lung cancer. Osimertinib (Tagrisso) in combination with pemetrexed and platinum-containing…
Researchers Find How Precision Radiation Therapy Supports In Lung Cancer Treatment
A recent study has been conducted by the researchers at The University of Texas MD Anderson Cancer Centre and the results of which were published in JAMA Oncology. According to this study,…
Nano Immunotherapy to Benefit Lung Cancer Patients
Lung cancer is the leading cancer death cause on a global level and non-small cell lung cancer makes up about 85% of all lung cancer cases. One of the most common treatment…
FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer
Every year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration…
Understanding TIL Therapy for Lung Cancer
Lung cancer is the leading cause of cancer related deaths all around the world. Although there are various advanced treatment options and several approaches, the survival rate remains low. Here, in this…
An Overview of Platinum-based Chemotherapy for Lung Cancer
Chemotherapy is one of the most common forms of cancers treatments. The medication aims at destroying cancer cells. Platinum-based chemotherapy drugs are used to treat various cancer types such as lung, breast,…
Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of patients with early stage, anaplastiv lymphoma kinase-positive non-small…